Discovery and Development of a New Insulin Sensitizing Agent, Pioglitazone.

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.122.909
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Insulin-Mimetic and Insulin-Sensitizing Activities of a Pentacyclic Triterpenoid Insulin Receptor Activator

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2007English

Insulin Sensitizing Agents and Polycystic Ovary Syndrome

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1998English

The IRIS (Insulin Resistance Intervention After Stroke) Trial: A New Perspective on Pioglitazone

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2016English

Insulin Sensitizing and Insulinotropic Action of Berberine From Cortidis Rhizoma

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2005English

The Discovery and Development of Analgesics: New Mechanisms, New Modalities

Journal of Clinical Investigation
Medicine
2010English

Development of a New Indolocarbazole Anticancer Agent(NB-506).

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry
Organic Chemistry
1997English

Pioglitazone Acutely Reduces Energy Metabolism and Insulin Secretion in Rats

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Almiramides A−C: Discovery and Development of a New Class of Leishmaniasis Lead Compounds

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Agent-Based Resource Discovery

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy